Click Here to return To Results

 

Intracranial Atherosclerotic Disease: An Update Ann Neurol 66:730-738, Qureshi,A.,et al, 2009 See this aricle in Pubmed Article Abstract In patients with intracranial atherosclerotic disease, short-term and long-term anticoagulation is not superior to antiplatelet treatment. Overall, the subgroup analyses from randomized trials provide evidence about benefit of aggressive atherogenic risk factor management. Intracranial angioplasty with or without stent placement has evolved as a therapeutic option for patients with symptomatic intracranial atherosclerotic disease, particularly those with high-grade stenosis with recurrent ischemic symptoms, medication failure, or both. A multicenter randomized trial is currently under way to compare stent placement with intense medical management for patients with high-grade symptomatic intracranial atherosclerotic disease.

Related Tags

(click to filter results - removes previous filter) anticoagulant,treatment anticoagulant,treatment in CVD carotid artery disease,medical management carotid artery stenosis,intracranial cerebral atherosclerosis cerebrovascular accident,recurrent cerebrovascular disease cerebrovascular disease,risk factors in platelet inhibiting drugs recurrent review article risk factors risk factors,modification stent,intracranial transluminal angioplasty,intracranial treatment of neurologic disorder

Click Here to return To Results